Knowledge of strategies to promote optimal quality of life for PD patients is of paramount importance for caregivers, health providers and patients themselves.

Parkinson's disease is a neurological disorder with evolving layers of complexity. Select all / Deselect all. Parkinson's disease (PD) is a common neurodegenerative disease that mainly occurs in the elderly [1,2]. A Brief Review on Parkinson’s Disease Citation: Anna Pratima Nikalje., et al. Sign in to set up alerts .

Open Peer Review Any reports and responses or comments on the article can be found at the end of the article. Although it more commonly develops in people in their 60s or older, it can occur as early as age 20 [2]. Parkinson's disease is a common movement disorder seen in neurological practice, but the diagnosis and management is challenging. Parkinson disease is the second-most common neurodegenerative disorder that affects 2–3% of the population ≥65 years of age. However, definitive disease-modifying therapy is still lacking. Parkinson’s Disease. It has long been characterised by the classical motor features of parkinsonism associated with Lewy bodies and loss of dopaminergic neurons in the substantia nigra. Show all article previews Show all article previews. The diagnosis is clinical and sometimes difficult, considering a large number of motor and non-motor symptoms in PD patients. EC Pharmacology and Toxicology 6.7 (2018): 509-527. Download PDFs Export citations. Last update 13 February 2019.

The medical management of PD patients is dif …

More than 1 million people in the United States have Parkinson’s disease. Experimental therapies are being developed and tested with limited results. Receive an update when the latest issues in this journal are published. Actions for selected articles. SYSTEMATIC REVIEW A systematic review and meta-analysis of safety and efficacy of safinamide for motor fluctuations in patients with Parkinson's disease [version 1; peer review: 2 approved, 1 approved with reservations] Parkinson's disease (PD) belongs to a group of conditions called motor system disorders, which are the result of the loss of dopamine producing brain cells. However, the symptomatology of Parkinson's disease is now recognised as heterogeneous, with clinically significant non-motor features. “A Brief Review on Parkinson’s Disease”.

Edited by Meg E Morris.